The short answer
Does Medicare Part D cover Wegovy? Yes, Medicare Part D covers Wegovy in 2026 if you have established cardiovascular disease. Additionally, the new 2026 Medicare GLP-1 Bridge Program provides $50 monthly access for eligible beneficiaries who meet specific body mass index and health condition requirements.
Key takeaways
- Medicare law strictly excludes coverage for drugs prescribed solely for weight loss.
- Part D plans cover Wegovy for patients with established cardiovascular disease and high BMI.
- The 2026 GLP-1 Bridge Program offers Wegovy for $50 a month to eligible seniors.
- Bridge Program costs do not count toward your 2026 or 2027 annual out-of-pocket caps.
- Your doctor must use exact diagnosis codes; "weight loss" will trigger an automatic denial.
- The Part D out-of-pocket cap is $2,100 in 2026, rising to $2,400 in 2027.
- You can spread your 2026 pharmacy costs into monthly payments using the Medicare Payment Plan.
In this article
- Does Medicare Part D Cover Wegovy in 2026 and 2027?
- The Weight Loss Exclusion Rule Explained
- When Wegovy Qualifies for Part D Cardiovascular Coverage
- The 2026 Medicare GLP-1 Bridge Program: A New Path for Coverage
- How Part D Plans Handle Prior Authorization for Wegovy
- What You Will Pay for Wegovy at the Pharmacy
- How Wegovy Costs Count Toward the Part D Annual Cap
- Using the Medicare Prescription Payment Plan for Wegovy
- What to Do If Your Part D Plan Denies Wegovy Coverage
- Common Mistakes When Trying to Get Wegovy Approved
- Steps to Check Your Plan Formulary Before Open Enrollment Ends
- Compare Part D Drug Plans in 30 Seconds
If you or a loved one are looking into weight management and heart health, you have likely asked: does Medicare Part D cover Wegovy? The rules surrounding Medicare and GLP-1 medications have changed significantly over the last few years. Navigating these changes can feel overwhelming, especially when you are trying to budget for your health care in retirement.
For a long time, the answer was a flat "no." However, thanks to updated federal guidelines and newly launched programs, the door to coverage has opened for many seniors. In 2026, Medicare Part D plans do cover Wegovy, but only under very specific medical circumstances. You cannot get it covered simply to lose weight, but you can get it covered to protect your heart or through a special new access program.
In this comprehensive guide, we will break down exactly how Wegovy coverage works in 2026, what changes are coming in 2027, and how you can navigate the strict prior authorization rules. We will also explore the brand-new Medicare GLP-1 Bridge Program, which offers a unique pathway to access this medication for just $50 a month.
Does Medicare Part D Cover Wegovy in 2026 and 2027?
The short answer is yes, but with strict conditions. Medicare Part D coverage for Wegovy depends entirely on why your doctor is prescribing it. Because Wegovy is widely known as a weight-loss medication, many people assume it is entirely blocked by Medicare rules. This is only partially true.
In 2026, your Medicare Part D plan will cover Wegovy if you meet the criteria for the cardiovascular exception. This means you must have an established history of heart disease, and the medication must be prescribed specifically to lower your risk of future major heart events, like a heart attack or stroke.
If you do not have heart disease, you may still have a path to coverage in 2026 and 2027. On July 1, 2026, a temporary nationwide initiative called the Medicare GLP-1 Bridge Program was launched. This program allows eligible beneficiaries with certain other health conditions to access Wegovy for a flat fee. We will explore both of these pathways in detail below.
The Weight Loss Exclusion Rule Explained
To understand why Wegovy coverage is so complicated, you have to look at how Medicare laws were written decades ago. When the Medicare Part D prescription drug program was created, Congress included a specific rule known as the statutory exclusion.
What the Law Says
By law, Medicare Part D cannot pay for any medication that is prescribed solely for the purpose of weight loss or weight management. This rule was put in place long before modern GLP-1 medications like Wegovy and Zepbound existed. At the time, lawmakers viewed weight-loss drugs as cosmetic or lifestyle medications rather than essential medical treatments.
Why the Rule Still Matters in 2026
Even though the medical community now recognizes obesity as a complex, chronic disease, the old Medicare law is still on the books. This means that if your doctor writes a prescription for Wegovy and lists "weight loss" or "obesity" as the only reason for the prescription, your Medicare Part D plan is legally required to deny it.
This statutory exclusion is the biggest hurdle for seniors trying to get Wegovy. To get coverage, your prescription must be tied to a different, FDA-approved medical condition that Medicare is allowed to cover. For more background on how other GLP-1s are handled, you can read our guide on whether Ozempic is covered by Medicare Part D.
When Wegovy Qualifies for Part D Cardiovascular Coverage
The landscape for Wegovy changed dramatically following a March 2024 guidance update from the Centers for Medicare & Medicaid Services (CMS). The FDA approved Wegovy for a new use: reducing the risk of major adverse cardiovascular events in adults who have established cardiovascular disease and who also have overweight or obesity.
The Cardiovascular Exception
Because Wegovy is now FDA-approved to treat heart disease risks, Medicare Part D plans are allowed to cover it for that specific purpose. This is known as the cardiovascular exception. It bypasses the weight-loss exclusion rule because the primary medical goal is protecting your heart, not just lowering your weight.
Who Qualifies for This Exception?
To get Wegovy covered under your standard Part D plan benefits in 2026, you must meet two main criteria:
- Established Cardiovascular Disease: You must have a documented history of heart disease. This typically means you have previously suffered a heart attack, a stroke, or have been diagnosed with peripheral arterial disease.
- High Body Mass Index (BMI): You must also have a BMI that classifies you as overweight (a BMI of 27 or higher) or obese (a BMI of 30 or higher).
Scenario: Mary's Cardiovascular Coverage
Let's look at an example. Mary is a 68-year-old Medicare beneficiary. She had a mild heart attack three years ago (established cardiovascular disease) and currently has a BMI of 31 (obesity). Her cardiologist prescribes Wegovy to lower her risk of having another heart attack. Because Mary meets both criteria, her Medicare Part D plan approves the prescription under the cardiovascular exception. Her costs will be based on her plan's standard copays and deductibles.
The 2026 Medicare GLP-1 Bridge Program: A New Path for Coverage
What happens if you have a high BMI and other health issues, but you have never had a heart attack or stroke? Until recently, you would have been completely out of luck. However, a major change took place in the middle of 2026.
What is the Bridge Program?
Launched on July 1, 2026, the Medicare GLP-1 Bridge Program is a temporary, nationwide initiative designed to help seniors who do not qualify for the cardiovascular exception. This program provides access to GLP-1 medications—including Wegovy—for eligible Part D beneficiaries. It is scheduled to run until December 31, 2027.
How Much Does It Cost?
If you qualify for the Bridge Program, you will pay a flat fee of $50 per month for your Wegovy prescription. This makes the medication highly affordable compared to paying the full retail price out of pocket.
Who is Eligible for the Bridge Program?
You must be 18 or older, enrolled in a Medicare Part D plan, and meet specific health criteria based on your BMI and other medical conditions. You qualify if you meet any of the following three tiers:
- Tier 1: You have a BMI of 35 or higher. (No additional health conditions are required).
- Tier 2: You have a BMI of 30 or higher AND you have been diagnosed with heart failure, uncontrolled high blood pressure, or chronic kidney disease (stage 3a or higher).
- Tier 3: You have a BMI of 27 or higher AND you have prediabetes or a history of a prior heart attack/stroke (if you somehow do not qualify through your standard plan).
Important Limits to the Bridge Program
While the $50 monthly cost is a massive relief for many, there is a catch. The $50 you pay each month through the Bridge Program does not count toward your Part D annual deductible, nor does it count toward your annual out-of-pocket maximum. It is treated as a separate, out-of-pocket program fee.
How Part D Plans Handle Prior Authorization for Wegovy
Whether you are trying to get Wegovy through the cardiovascular exception or the new GLP-1 Bridge Program, you will almost certainly have to go through a process called "prior authorization."
What is Prior Authorization?
Prior authorization is a rule that requires your doctor to get special approval from your Medicare Part D plan before the plan will agree to pay for the drug. Because Wegovy is an expensive medication, insurance companies use prior authorization to ensure it is being prescribed exactly according to Medicare's strict rules.
The Importance of Medical Coding
The success of your prior authorization request comes down to the paperwork your doctor submits. In the medical world, doctors use specific "ICD-10 codes" to tell the insurance company why a drug is being prescribed.
If your doctor submits a code for "weight management" or "obesity" as the primary reason, the Part D plan's computer system will automatically reject it due to the statutory exclusion law. To get approved under the cardiovascular exception, your doctor must use the specific ICD-10 code for your established cardiovascular disease.
Steps Your Doctor Must Take
To avoid delays at the pharmacy counter, make sure your doctor takes these steps:
- Documents your exact BMI in your medical chart.
- Clearly lists your history of cardiovascular events (like a past stroke or heart attack).
- Submits the prior authorization form with the cardiovascular diagnosis code as the primary reason for the prescription.
- Includes any required lab results or chart notes proving you meet the criteria.
What You Will Pay for Wegovy at the Pharmacy
If you qualify for Wegovy under the standard cardiovascular exception (not the Bridge Program), your costs will depend on the standard phases of Medicare Part D. Let's look at the official figures for 2026 and the projected changes for 2027.
The Annual Deductible
Before your plan starts paying for your Wegovy, you may have to meet your annual deductible.
- In 2026, the maximum allowable Part D deductible is $615.
- In 2027, the maximum deductible will increase to $700.
If your plan applies the deductible to the tier that Wegovy is on, you will have to pay the full negotiated price of the drug until you have spent that $615 (in 2026) out of your own pocket.
Initial Coverage Copays
Once your deductible is met, you enter the initial coverage phase. Here, you will pay a copay or coinsurance (a percentage of the drug's cost). Wegovy is usually placed on a higher "tier" (often Tier 3 or Tier 4) by Part D plans. This means you might pay a flat $45 copay, or you might pay 25% to 33% of the drug's total cost, depending on your specific plan's rules.
Monthly Premiums
Don't forget that you also pay a monthly premium just to have your drug plan. In 2026, the average stand-alone Part D premium is projected at $34.50. However, in 2027, average premiums are projected to rise to $51.00 as a temporary federal stabilization program comes to an end. It is vital to compare Part D drug plans every fall to make sure you aren't overpaying for your monthly premium.
| Medicare Part D Cost Limits | 2026 Rules | 2027 Rules |
|---|---|---|
| Maximum Annual Deductible | $615 | $700 |
| Annual Out-of-Pocket Cap | $2,100 | $2,400 |
| Average Monthly Premium | $34.50 | $51.00 |
| Base Beneficiary Premium (Penalty Base) | $38.99 | $41.33 |
How Wegovy Costs Count Toward the Part D Annual Cap
One of the best protections in Medicare Part D is the annual out-of-pocket maximum. This is a hard cap on how much you have to spend on covered medications in a single calendar year.
The 2026 and 2027 Caps
In 2026, the Part D out-of-pocket limit is capped at $2,100. Once your spending on covered deductibles, copays, and coinsurance reaches $2,100, you will pay $0 for your covered Part D drugs for the rest of the year.
In 2027, this out-of-pocket cap will increase slightly to $2,400. Even with the increase, this cap provides massive financial relief for seniors taking expensive brand-name medications like Wegovy. You can learn more about how this works in our guide on what counts toward the Part D cap.
Bridge Program Exception
It is crucial to remember that if you are getting Wegovy through the temporary 2026 GLP-1 Bridge Program, your costs work differently. The $50 you pay each month for the Bridge Program does not count toward your $2,100 limit in 2026 or your $2,400 limit in 2027. It is entirely separate from your standard Part D benefit tracking.
Using the Medicare Prescription Payment Plan for Wegovy
Even with an out-of-pocket cap of $2,100 in 2026, paying for a high-tier drug like Wegovy early in the year can be a shock to your budget. If you have to pay a $615 deductible plus a 25% coinsurance in January, your first trip to the pharmacy could cost hundreds of dollars.
Spreading Out Your Costs
To help with this, Medicare introduced the Medicare Prescription Payment Plan (MPPP), which continues in 2026 and 2027. This program allows you to opt-in and spread your out-of-pocket drug costs over the calendar year in monthly installments, rather than paying a massive lump sum at the pharmacy counter.
Scenario: Robert Uses the Payment Plan
Robert gets Wegovy approved under the cardiovascular exception in January 2026. At the pharmacy, his total cost for the first fill (including his $615 deductible) would normally be $800. Instead of paying $800 all at once, Robert opts into the Medicare Prescription Payment Plan.
His plan takes his projected maximum out-of-pocket costs for the year (up to the $2,100 cap) and divides them into manageable monthly bills. Robert leaves the pharmacy paying $0 that day, and instead receives a monthly bill from his insurance company for a fraction of the cost. If you are worried about upfront costs, read our article to see if the Medicare Prescription Payment Plan is worth it for you.
What to Do If Your Part D Plan Denies Wegovy Coverage
Because the rules are so strict, it is very common for a Wegovy prescription to be denied on the first try. If you go to the pharmacy and the pharmacist tells you that Medicare will not pay for it, do not panic. You have the right to appeal.
Step 1: Find Out Why It Was Denied
Ask the pharmacist for the exact denial code or message. Usually, it is because the prior authorization was not completed, or because the doctor used a "weight loss" diagnosis code instead of a cardiovascular code.
Step 2: Talk to Your Doctor
Contact your prescribing doctor's office immediately. Explain that the medication was denied. Ask them to review the prior authorization paperwork. If they simply forgot to include your history of heart disease, they can resubmit the form with the correct ICD-10 codes.
Step 3: File a Formal Appeal
If your plan still denies the coverage even with the correct cardiovascular codes, you can file a formal appeal (called a redetermination). Your plan must give you instructions on how to do this in writing. You will need your doctor to write a letter of medical necessity explaining exactly why you need Wegovy to prevent a future cardiovascular event.
Common Mistakes When Trying to Get Wegovy Approved
Navigating Medicare Part D rules can feel like walking through a maze. Here are the most common mistakes seniors make when trying to get Wegovy covered:
- Assuming weight alone is enough: Many people think that because their BMI is very high, Medicare has to cover it. Under standard Part D rules, weight alone is never enough due to the statutory exclusion. (Unless you apply for the special Bridge Program).
- Not checking the formulary: Every Part D plan has a list of covered drugs called a formulary. Even if you have heart disease, your specific plan might prefer a different medication. Always check your plan's formulary before the year begins.
- Ignoring the Late Enrollment Penalty: If you delayed signing up for Part D when you first turned 65, you might face a late enrollment penalty. This penalty is 1% of the national base premium (which is $38.99 in 2026) for every month you went without coverage. This penalty is added to your monthly premium permanently.
Steps to Check Your Plan Formulary Before Open Enrollment Ends
Medicare Fall Open Enrollment runs from October 15 through December 7 every year. This is your chance to change your Part D plan for the upcoming year. If you plan to take Wegovy in 2027, you must verify that your new plan covers it.
How to Verify Coverage
- Gather your drug list: Write down Wegovy, along with the exact dosage, and all other medications you take.
- Review the Annual Notice of Change: If you are keeping your current plan, read the notice they send you in September. Look for any changes to Wegovy's tier or prior authorization requirements for 2027.
- Look for Restrictions: When comparing new plans, don't just look to see if Wegovy is on the list. Look for the letters "PA" (Prior Authorization) or "QL" (Quantity Limits). You will need to know what hoops you have to jump through.
Compare Part D Drug Plans in 30 Seconds
Finding a Medicare Part D plan that covers your specific medications at a price you can afford shouldn't take hours of frustrating research. At Genie Medicare, we make the process incredibly fast and simple.
You can compare Part D drug plan rates in your ZIP code in about 30 seconds. We believe in transparency, so you will see real prices immediately—no name, phone number, or email address required. If you also want to look into combining your health and drug coverage, you can easily compare Medicare Advantage rates as well. And if you ever want free help navigating the Wegovy rules, our licensed agents are just a click away.
Let Genie grant your Medicare rate wish
Compare Part D Drug Plans rates in about 30 seconds. No name, phone or email needed to see prices.
Frequently asked questions
Does Medicare Part D cover Wegovy for weight loss in 2026?
No, Medicare Part D does not cover Wegovy if it is prescribed solely for weight loss. Federal law strictly excludes weight-loss medications from standard Part D coverage. However, it can be covered if prescribed to reduce cardiovascular risks in patients with established heart disease.
How much does Wegovy cost with Medicare in 2026?
If approved under the cardiovascular exception, you must first meet your 2026 deductible of up to $615, then pay your plan's tier copay until you reach the $2,100 out-of-pocket cap. If you use the 2026 GLP-1 Bridge Program, you pay a flat $50 per month.
What is the Medicare GLP-1 Bridge program and how do I apply?
Launched in July 2026, the Bridge Program provides Wegovy for $50 a month to Part D enrollees who meet specific BMI and health criteria, even without heart disease. You can apply through your Part D plan provider by having your doctor submit proof of your qualifying health conditions.
Why does Medicare cover semaglutide (Ozempic/Wegovy) for some patients and not others?
Coverage depends on the FDA-approved diagnosis. Medicare covers Ozempic for Type 2 diabetes, and Wegovy for cardiovascular risk reduction in patients with heart disease. By law, Medicare cannot cover either drug if the only medical diagnosis provided by the doctor is weight loss.
What should I do if my Medicare Part D plan denies my Wegovy prescription?
First, ask your pharmacist for the denial reason. Often, it is because your doctor used a weight-loss diagnosis code instead of a cardiovascular code. Contact your doctor to correct and resubmit the prior authorization paperwork. If denied again, you have the right to file a formal appeal.
Do my $50 Bridge Program payments count toward the Part D out-of-pocket cap?
No, the $50 monthly fee you pay through the temporary Medicare GLP-1 Bridge Program does not count toward your $2,100 Part D out-of-pocket cap in 2026, nor does it count toward your deductible. It is treated as a separate program fee.
Sources
This article is for general information and isn't insurance, medical, legal or tax advice. Plan costs and benefits change every year and depend on where you live, your age and your health. Genie Medicare is not connected with or endorsed by the U.S. government or the federal Medicare program.